Technical Analysis for TYME - Tyme Technologies, Inc.

Grade Last Price % Change Price Change
grade C 6.09 -0.98% -0.06
TYME closed down 0.98 percent on Friday, January 19, 2018, on 3.67 times normal volume. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.
1 Watcher
Track This Stock
Watchlist Portfolio

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Up Down
See historical TYME trend table...

Date Alert Name Type % Chg
Jan 19 Shooting Star Candlestick Bearish 0.00%
Jan 19 1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Jan 19 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Jan 19 Volume Surge Other 0.00%
Jan 19 Wide Bands Range Expansion 0.00%
Jan 19 Lower Bollinger Band Touch Weakness 0.00%
Jan 19 Oversold Stochastic Weakness 0.00%
Jan 18 Wide Bands Range Expansion -0.98%
Jan 18 Oversold Stochastic Weakness -0.98%
Jan 17 Hammer Candlestick Bullish -13.00%

Older signals for TYME ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Tyme Technologies, Inc., formerly Global Group Enterprises Corp., conducts majority of its research and development activities and other business operations, through its subsidiary, Tyme Inc. (Tyme). Tyme is a clinical-stage biopharmaceutical company. Tyme is focused on the development and commercialization of highly targeted cancer therapeutics with a range of oncology indications. The Company's another subsidiary, Luminant Biosciences, LLC, conducts the initial research and development of the Company's therapeutic platform. The Company is formulating its regulatory and drug development program for its lead drug candidate, SM-88, and working towards the initiation of its Phase II clinical trial. The Company is also evaluating the expansion of its Phase II program to other types of cancer. The Company has not generated any revenue.
Is TYME a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 9.5
52 Week Low 3.2
Average Volume 176,648
200-Day Moving Average 0.0
50-Day Moving Average 4.999
20-Day Moving Average 6.666
10-Day Moving Average 6.631
Average True Range 0.6537
ADX 34.64
+DI 22.16
-DI 18.78
Chandelier Exit (Long, 3 ATRs ) 6.3389
Chandelier Exit (Short, 3 ATRs ) 5.6211
Upper Bollinger Band 7.2817
Lower Bollinger Band 6.0503
Percent B (%b) 0.03
BandWidth 18.472847
MACD Line 0.4321
MACD Signal Line 0.5675
MACD Histogram -0.1355
Fundamentals Value
Market Cap 543.96 Million
Num Shares 89.3 Million
EPS -0.14
Price-to-Earnings (P/E) Ratio -43.50
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.67
Resistance 3 (R3) 7.79 7.40 7.40
Resistance 2 (R2) 7.40 7.00 7.33 7.31
Resistance 1 (R1) 6.74 6.75 6.55 6.62 7.23
Pivot Point 6.35 6.35 6.25 6.28 6.35
Support 1 (S1) 5.69 5.95 5.50 5.57 4.95
Support 2 (S2) 5.30 5.70 5.23 4.87
Support 3 (S3) 4.64 5.30 4.78
Support 4 (S4) 4.52